Multi-Organ metabolic profiling with [18F]F-FDG PET/CT predicts pathological response to neoadjuvant immunochemotherapy in resectable NSCLC.
Purpose: To develop and validate a novel nomogram combining multi-organ PET metabolic metrics for major pathological response (MPR) prediction in resectable non-small cell lung cancer (rNSCLC) patients receiving neoadjuvant immunochemotherapy. Methods: This retrospective cohort included rNSCLC patie...
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 53; no. 1; pp. 128 - 142 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |